This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Solid Organ Transplantation
  • /
  • Study of Efficacy, Safety, Tolerability, Pharmacok...
Clinical trial

Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients (CIRRUS I)

Read time: 1 mins
Last updated:11th Mar 2020
Identifier: NCT03663335
Register free for full access to medthority.com